by Life science tools such as microarray analysis tools, label-free detection tools, and single- cell analysis systems hold immense potential for the advancement of genomics, proteomics, and drug discovery. These tools aid in the identification of disease-causing genetic variations, analysis of variations among people, characterization of genetic predispositions to disease, and development of novel therapeutic agents. The global life science tools market is dominated by tools for genomics, proteomics, cell analysis, and drug discovery due to rising demand from hospitals, diagnostic laboratories, academic institutes, and pharmaceutical & biotechnology companies for applications in precision medicine and disease treatment. The global Life Science Tools Market is estimated to be valued at US$ 144.22 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological advancements are a key trend driving growth of the Global Life Science Tools Market Size. Ongoing development of innovative tools characterized by higher throughput, enhanced resolution, advanced connectivity, and miniaturization has expanded the scope of life science research. For instance, quantitative real-time PCR systems allow accurate gene expression analysis, microarray analysis tools facilitate genotyping and gene expression studies, and next-generation sequencing platforms have revolutionized DNA sequencing. Adoption of such frontier technologies has augmented capabilities for advanced applications in drug discovery, precision medicine, clinical diagnosis, and synthetic biology. Growing R&D funding from both private and public organizations to support development of sophisticated life science tools will further propel the market during the forecast period.
Porter’s Analysis:
Threat of new entrants: The life science tools market requires high initial capital investments and established distribution networks, lowering the threat of new entrants. Existing players have significant economies of scale.
Bargaining power of buyers: Individual buyers have moderate bargaining power as there are many established suppliers in this fragmented market. However, large organization buyers may enjoy better purchasing terms.
Bargaining power of suppliers: A few dominant multinational corporations supply core life science tools, giving them some bargaining power over pricing and product development.
Threat of new substitutes: There is a low threat from substitutes as life science tools have highly specialized applications in research and drug development without close substitutes.
Competitive rivalry: Competition is high among many global and regional providers as the market is fragmented. Players compete based on pricing, innovation, and overall product quality.
Key Takeaways:
The global life science tools market is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis: North America accounts for the largest share of the global market currently due to rising biotechnology and pharmaceutical research activities. The U.S. is the major contributor owing to availability of research funding and continuous technology advancements. Asia Pacific market is anticipated to witness the highest CAGR during the forecast period owing to growing medical tourism sector and established healthcare infrastructure. Government initiatives supporting life science research will further drive the APAC life science tools market.
Key players operating in the life science tools market are Mayo Clinic, Liquid Instrument Mfg., Thermo Fisher Scientific Inc., Merck KGaA , PerkinElmer Inc., Danaher Corporation. Players compete based on their product portfolio and pricing strategies to gain higher market share. They collaborate with research institutes and hospitals to develop innovative products.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
